Factors Associated With Cancer Treatment Delay Among Patients Diagnosed With COVID-19
Open Access
- 28 July 2022
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 5 (7) , e2224296
Abstract
As a result of system- and patient-level factors related to the COVID-19 pandemic, cancer care has frequently been delayed or altered. For example, recent data showed that half of European breast centers altered systemic treatments during the pandemic and one-fifth of patients experienced delay in radiation therapy.1 Professional societies quickly released guidance to amend care guidelines during a time of great uncertainty, prior to vaccines and other therapies.2-6 These guidelines helped clinicians prioritize patients with higher-risk disease to avoid treatment delays and suggested alternatives, such as beginning systemic therapy first to permit surgical treatment to be delayed.7,8 Changes to conventional treatment plans have subsequently been studied for associations with outcomes.9,10 Such studies help researchers identify cancers and clinical settings in which delays are not associated with overall survival, as well as situations in which delays in treatment truly are harmful.11 However, these studies have largely assessed the impact of the pandemic among patients with cancer who did not contract COVID-19 themselves.Keywords
This publication has 23 references indexed in Scilit:
- Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST)The Breast, 2020
- Economic Vulnerability of Households With Essential WorkersJAMA, 2020
- Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort studyThe Lancet Oncology, 2020
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyThe Lancet, 2020
- Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 OutbreakCancer Discovery, 2020
- Global guidance for surgical care during the COVID-19 pandemicBritish Journal of Surgery, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Vulnerable populations: who are they?2006